Related Experiment Video
Updated: Jun 10, 2026
Isolation of Perivascular Multipotent Precursor Cell Populations from Human Cardiac Tissue
Published on: October 8, 2016
Cardiac regeneration with novel bone marrow-derived multipotent stem cells
1Division of Cardiovascular Research, Caritas St. Elizabeth's Medical Center, Tufts University School of Medicine, 736 Cambridge Street, Boston, MA 02135, USA.
Insights
Heart failure, often caused by heart attack damage, lacks effective treatments for regenerating cardiac muscle. Stem cell therapy offers a promising new approach for repairing heart tissue and improving outcomes.
Area of Science:
- Cardiovascular Medicine
- Regenerative Medicine
- Stem Cell Biology
Background:
- Congestive heart failure (CHF) is a global epidemic, primarily driven by irreversible myocardial damage from myocardial infarction (MI).
- The adult myocardium has a limited capacity for self-repair, leading to cardiomyocyte loss, fibrosis, and progressive heart failure.
- Current treatments cannot replace scar tissue with functional contractile tissue, highlighting a critical unmet medical need.
Purpose of the Study:
- To explore novel therapeutic strategies for repairing myocardial damage and addressing the pathophysiology of heart failure.
- To investigate the potential of cell therapy, specifically using stem cells, for regenerating damaged cardiac tissue post-MI.
Main Methods:
- Review of existing literature on myocardial infarction, heart failure, and cardiac regeneration.
- Analysis of the role of cardiomyocyte survival and loss in heart failure progression.
- Exploration of stem cell capabilities in tissue regeneration.
Main Results:
- Myocardial infarction leads to irreversible loss of cardiomyocytes and functional tissue, initiating a cascade towards progressive heart failure.
- Loss of cardiomyocyte survival cues is linked to various heart failure pathways.
- The identification of regenerative stem cells presents a potential avenue for therapeutic intervention.
Conclusions:
- Significant morbidity and mortality associated with MI and heart failure necessitate new treatment approaches.
- Stem cell therapy is emerging as a promising strategy for myocardial repair by potentially replacing damaged tissue with functional cells.
- Further research into cell therapy is warranted to address the deficits caused by cardiomyocyte and blood vessel loss.
Abstract:
Extract: Congestive heart failure is a growing, worldwide epidemic. The major causes of heart failure are related to irreversible damage resulting from myocardial infarction. The long-standing axiom has been that the myocardium has a limited capacity for self-repair or regeneration; and the irreversible loss of cardiac muscle and accompanying contraction and fibrosis of myocardial scar tissue sets into play a series of events that ultimately lead to progressive heart failure. The loss of cardiomyocyte survival cues is associated with diverse pathways for heart failure, underscoring the importance of maintaining the number of viable cardiomyocytes during heart failure progression. Currently, no medication or procedure used clinically has shown efficacy in replacing the myocardial scar with functioning contractile tissue. Therefore, given the major morbidity and mortality associated with myocardial infarction and heart failure, new approaches have been sought to address the principal pathophysiologic deficits responsible for these conditions, resulting from the loss of cardiomyocytes and viable blood vessels (and hence an adequate oxygen supply). Recently, the identification of stem cells capable of contributing to tissue regeneration has ignited significant interest in the possibility that cell therapy could be employed therapeutically for the repair of damaged myocardium.
Related Concept Videos
01:21Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
01:19Multipotency of Hematopoietic Stem Cells
01:17Stem Cell Culture